rs111033590
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_213655.5(WNK1):c.3301C>T(p.Gln1101Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
WNK1
NM_213655.5 stop_gained
NM_213655.5 stop_gained
Scores
4
3
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 12-868772-C-T is Pathogenic according to our data. Variant chr12-868772-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 5166.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-868772-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WNK1 | NM_213655.5 | c.3301C>T | p.Gln1101Ter | stop_gained | 10/28 | ENST00000340908.9 | NP_998820.3 | |
WNK1 | NM_018979.4 | c.2140-2493C>T | intron_variant | ENST00000315939.11 | NP_061852.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WNK1 | ENST00000340908.9 | c.3301C>T | p.Gln1101Ter | stop_gained | 10/28 | 5 | NM_213655.5 | ENSP00000341292 | A2 | |
WNK1 | ENST00000315939.11 | c.2140-2493C>T | intron_variant | 1 | NM_018979.4 | ENSP00000313059 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249232Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135210
GnomAD3 exomes
AF:
AC:
5
AN:
249232
Hom.:
AF XY:
AC XY:
3
AN XY:
135210
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461688Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727130
GnomAD4 exome
AF:
AC:
10
AN:
1461688
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 2A Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 24, 2005 | - - |
not provided, no classification provided | literature only | GeneReviews | - | French Canadian founder variants - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2022 | The p.Q1101* pathogenic mutation (also known as c.3301C>T), located in coding exon 10 of the WNK1 gene, results from a C to T substitution at nucleotide position 3301. This changes the amino acid from a glutamine to a stop codon within coding exon 10. This alteration was detected in the homozygous state in an individual with hereditary sensory and autonomic neuropathy type II; however, clinical details were limited (Lafreniere RG et al. Am J Hum Genet, 2004 May;74:1064-73). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;A;A;A;A
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at